Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Recruitment experience in clinical trials: literature summary and annotated bibliography.

Hunninghake DB, Darby CA, Probstfield JL.

Control Clin Trials. 1987 Dec;8(4 Suppl):6S-30S. Review.

PMID:
3326716
2.

Recruitment for controlled clinical trials: literature summary and annotated bibliography.

Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL.

Control Clin Trials. 1997 Aug;18(4):328-52.

PMID:
9257072
3.

Involving South Asian patients in clinical trials.

Hussain-Gambles M, Leese B, Atkin K, Brown J, Mason S, Tovey P.

Health Technol Assess. 2004 Oct;8(42):iii, 1-109. Review.

4.

American Society of Clinical Oncology policy statement: oversight of clinical research.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2377-86. Epub 2003 Apr 29.

PMID:
12721281
5.

An institutional strategy to increase minority recruitment to therapeutic trials.

Anwuri VV, Hall LE, Mathews K, Springer BC, Tappenden JR, Farria DM, Jackson S, Goodman MS, Eberlein TJ, Colditz GA.

Cancer Causes Control. 2013 Oct;24(10):1797-809. doi: 10.1007/s10552-013-0258-1. Epub 2013 Jul 12.

6.

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, Devine P, Dilts DM, Duff ME, Ford JG, Joffe S, Schapira L, Weinfurt KP, Michaels M, Raghavan D, Richmond ES, Zon R, Albrecht TL, Bookman MA, Dowlati A, Enos RA, Fouad MN, Good M, Hicks WJ, Loehrer PJ Sr, Lyss AP, Wolff SN, Wujcik DM, Meropol NJ.

J Oncol Pract. 2013 Nov;9(6):267-76. doi: 10.1200/JOP.2013.001119. Epub 2013 Oct 15.

7.

Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.

Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, Entwistle V, Garcia J, Roberts I, Grant A, Grant A; STEPS group.

Health Technol Assess. 2007 Nov;11(48):iii, ix-105. Review.

8.

A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations.

Friedman DB, Foster C, Bergeron CD, Tanner A, Kim SH.

Am J Health Promot. 2015 May-Jun;29(5):332-8. doi: 10.4278/ajhp.130514-QUAL-247. Epub 2014 Mar 26.

PMID:
24670073
9.

Accrual and recruitment practices at Clinical and Translational Science Award (CTSA) institutions: a call for expectations, expertise, and evaluation.

Kost RG, Mervin-Blake S, Hallarn R, Rathmann C, Kolb HR, Himmelfarb CD, D'Agostino T, Rubinstein EP, Dozier AM, Schuff KG.

Acad Med. 2014 Aug;89(8):1180-9. doi: 10.1097/ACM.0000000000000308.

10.

Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.

Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR.

Clin Trials. 2011 Apr;8(2):214-23. doi: 10.1177/1740774510396742. Epub 2011 Jan 17.

11.

Projection of participant recruitment to primary care research: a qualitative study.

White D, Hind D.

Trials. 2015 Oct 20;16:473. doi: 10.1186/s13063-015-1002-9.

12.

Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base? [Internet].

Abernethy AP, Allen Lapointe NM, Wheeler JL, Irvine RJ, Patwardhan M, Matchar D.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Aug 28.

13.

Provider roles in the recruitment of underrepresented populations to cancer clinical trials.

Howerton MW, Gibbons MC, Baffi CR, Gary TL, Lai GY, Bolen S, Tilburt J, Tanpitukpongse TP, Wilson RF, Powe NR, Bass EB, Ford JG.

Cancer. 2007 Feb 1;109(3):465-76.

14.
15.

Improving clinical trial accrual through a novel feedback approach: Lessons learned from a single disease site group.

D'Alimonte L, Deabreu A, Marquez A, Mamedov A, Loblaw A.

Pract Radiat Oncol. 2015 Mar-Apr;5(2):70-3. doi: 10.1016/j.prro.2014.05.009. Epub 2014 Jul 3.

PMID:
25413410
17.

Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.

Ellis SD, Carpenter WR, Minasian LM, Weiner BJ.

Contemp Clin Trials. 2012 Sep;33(5):933-41. doi: 10.1016/j.cct.2012.06.001. Epub 2012 Jun 8.

18.

Asian Americans and cancer clinical trials: a mixed-methods approach to understanding awareness and experience.

Paterniti DA, Chen MS Jr, Chiechi C, Beckett LA, Horan N, Turrell C, Smith L, Morain C, Montell L, Luis Gonzalez J, Davis S, Lara PN Jr.

Cancer. 2005 Dec 15;104(12 Suppl):3015-24.

19.

Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study.

Raftery J, Bryant J, Powell J, Kerr C, Hawker S.

Health Technol Assess. 2008 Apr;12(10):1-128, iii.

20.

Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual.

Mileham KF, Kim ES.

Clin Cancer Res. 2016 Nov 15;22(22):5397-5399. doi: 10.1158/1078-0432.CCR-16-1710. Epub 2016 Sep 6.

Supplemental Content

Support Center